Gelteq Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand
Gelteq (NASDAQ: GELS) announces that its largest U.S. customer, Healthy Extracts, has increased its initial purchase order of collagen and Mynus sugar blocker gels by 50% due to high market demand. The production is underway with shipment expected in January 2025. This expansion follows Gelteq's strategic U.S. market entry, including the recent appointment of Adam Bendell as U.S. President. The partnership aims to provide improved delivery solutions for nutraceutical products, focusing on easier digestion and better absorption.
Gelteq (NASDAQ: GELS) annuncia che il suo maggiore cliente statunitense, Healthy Extracts, ha aumentato il suo ordine iniziale di gel di collagene e bloccanti di zucchero Mynus del 50% a causa dell'alta domanda del mercato. La produzione è in corso e la spedizione è prevista per gennaio 2025. Questa espansione segue l'ingresso strategico di Gelteq nel mercato statunitense, inclusa la recente nomina di Adam Bendell come Presidente degli Stati Uniti. La partnership ha l'obiettivo di fornire soluzioni di consegna migliorate per i prodotti nutraceutici, con un focus su una digestione più facile e una migliore assorbimento.
Gelteq (NASDAQ: GELS) anuncia que su mayor cliente en los EE. UU., Healthy Extracts, ha aumentado su pedido inicial de geles de colágeno y bloqueadores de azúcar Mynus en un 50% debido a la alta demanda del mercado. La producción está en marcha y se espera el envío para enero de 2025. Esta expansión sigue la entrada estratégica de Gelteq en el mercado estadounidense, incluida la reciente designación de Adam Bendell como Presidente de EE. UU. La asociación tiene como objetivo proporcionar soluciones de entrega mejoradas para productos nutracéuticos, centrándose en una digestión más fácil y una mejor absorción.
겔테크(Gelteq) (NASDAQ: GELS)는 미국 최대 고객인 헬시 익스트랙트(Healthy Extracts)가 높은 시장 수요로 인해 콜라겐 및 마이너스 설탕 차단제 젤의 초기 주문을 50% 증가시켰다고 발표했습니다. 생산은 진행 중이며 2025년 1월에 배송될 예정입니다. 이 확장은 겔테크의 전략적 미국 시장 진입에 따르며, 최근 아담 벤델을 미국 사장으로 임명한 것을 포함합니다. 이 파트너십은 영양 제품을 위한 개선된 배송 솔루션을 제공하고, 더 쉬운 소화와 더 나은 흡수에 중점을 둡니다.
Gelteq (NASDAQ: GELS) annonce que son plus grand client américain, Healthy Extracts, a augmenté sa commande initiale de gels de collagène et de bloqueurs de sucre Mynus de 50% en raison d'une forte demande sur le marché. La production est en cours, avec une expédition prévue en janvier 2025. Cette expansion fait suite à l'entrée stratégique de Gelteq sur le marché américain, y compris la récente nomination d'Adam Bendell en tant que Président des États-Unis. Le partenariat vise à fournir des solutions de livraison améliorées pour les produits nutraceutiques, en mettant l'accent sur une digestion plus facile et une meilleure absorption.
Gelteq (NASDAQ: GELS) gibt bekannt, dass sein größter US-Kunde, Healthy Extracts, seinen ursprünglichen Einkaufsauftrag für Kollagen- und Mynus-Zuckerblockergel um 50% aufgrund der hohen Marktnachfrage erhöht hat. Die Produktion läuft bereits, und der Versand wird für Januar 2025 erwartet. Diese Expansion folgt dem strategischen Markteintritt von Gelteq in den USA, einschließlich der kürzlichen Ernennung von Adam Bendell zum US-Präsidenten. Die Partnerschaft zielt darauf ab, verbesserte Lieferlösungen für nutraceutical Produkte anzubieten, wobei der Fokus auf einer einfacheren Verdauung und besseren Absorption liegt.
- 50% increase in initial purchase order from largest U.S. customer
- Expansion of U.S. market presence through strategic partnership
- Production already underway for increased order volume
- Potential for higher margins and accelerated revenue growth
- None.
Insights
This 50% order increase from Healthy Extracts signals strong market validation for Gelteq's gel-based delivery technology in the U.S. nutraceutical market. The expanded purchase order reflects robust consumer demand and could indicate accelerating market penetration. For a small-cap company with a market cap of
The partnership's focus on collagen and sugar blocker products targets high-growth segments within the nutraceutical market. The planned expansion of product offerings in early 2025 suggests potential for sustained revenue growth. However, investors should note that specific financial terms and order values weren't disclosed, making it challenging to quantify the direct revenue impact. The company's strategic U.S. market entry, supported by new leadership and infrastructure, positions it for potential broader market penetration in the world's largest nutraceutical market.
Healthy Extracts expands order after high demand for Gelteq’s collagen and Mynus sugar blocker gels
NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company that is focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, and other products, announces its largest U.S. customer, Healthy Extracts (OTCQB:HYEX), has increased its initial purchase order of Gelteq collagen and Mynus sugar blocker gels by
This growing partnership supports Gelteq’s strategic push into the U.S. market following the recent hiring of Adam Bendell as the Company’s U.S. President and the establishment of a U.S.-based office. Production of Healthy Extracts’ order is underway, with shipment expected in January 2025.
“Gelteq is dedicated to delivering products offering an improved delivery platform to those who may struggle to swallow or digest traditional nutraceutical products, which we anticipate will result in improved commercial success,” Gelteq Co-Founder and CEO Nathan Givoni said. “Our partnership with Healthy Extracts is a perfect example of how our formulations can create a revolutionary and convenient way for consumers to ingest the product with the added benefits of easier digestion and better absorption. We believe the increase in demand is a testament to our innovative products and a positive step forward in our commitment to building long-term shareholder value.”
“Gelteq’s advanced technology offers a cutting-edge delivery system that empowers us to expand existing sales channels and capitalize on new market opportunities, all while delivering a more satisfying and impactful experience for consumers. This partnership is poised to drive higher margins, accelerate revenue growth, and strengthen our leadership in the rapidly expanding U.S. health and wellness market. We are confident that Gelteq's collaboration will be a pivotal factor in driving the sustained growth and success of our business,” said Duke Pitts, Healthy Extracts President.
Gelteq and the Healthy Extracts team will continue to expand the range of their partnership and expect to announce new products in early 2025.
About Gelteq Inc.
Headquartered in Melbourne, Australia, Gelteq (NASDAQ: GELS) is a clinical and science-based company that is focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. Gelteq is focused on advancing and commercializing its delivery solutions within five core verticals: pharmaceuticals, over-the-counter medications, nutraceuticals, animal medications, and sports nutrition. Gelteq’s unique formulation directly addresses the issues associated with traditional drug delivery methods such as difficulty swallowing, taste of unpalatable ingredients, and dosage control. For more information, visit www.gelteq.com.
About Healthy Extracts
Healthy Extracts Inc. is a platform for acquiring, developing, researching, patenting, marketing, and distributing plant-based nutraceuticals. The company’s subsidiaries, BergametNA™ and Ultimate Brain Nutrients™ (UBN), offer nutraceutical natural heart and brain health supplements. This includes the only heart health supplement distributed in North America containing Citrus Bergamot SuperFruit™. This superfruit has the highest known concentration of polyphenols and flavonoids. UBN’s KETONOMICS® proprietary formulations, which have been designed to enhance brain activity, focus, headache and cognitive behavior, provide many sales and intellectual property licensing opportunities.
For more information visit: healthyextractsinc.com, bergametna.com or tryubn.com.
Forward-Looking Statements
Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “suggest,” “target,” “aim,” “should,” "will,” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Gelteq’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict, including risks related to the timing and fulfilment of current and future orders relating to Gelteq’s products, the success of new programs, the ability to implement a new strategic plan and the success of a new strategic plan. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Gelteq in general, see the risk factors in the final prospectus filed on October 22, 2024. All such forward-looking statements speak only as of the date they are made, and Gelteq undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise.
| Contact: CORE IR 516-222-2560 PR@gelteq.com |
FAQ
When will Gelteq (GELS) ship the increased order to Healthy Extracts?
By what percentage did Healthy Extracts increase their order of Gelteq (GELS) products?
What products are included in Healthy Extracts' increased order from Gelteq (GELS)?
When will Gelteq (GELS) announce new products with Healthy Extracts?
